ONCOLOGY NURSING FORUM, published by the ONCOLOGY NURSING SOCIETY, is a premier journal dedicated to advancing the field of oncology nursing through rigorous research and scholarly discussion. Established in 1977, this journal has a rich history of contributing to the professional development of oncology nurses, with the latest convergence extending to 2024. With an impressive Scopus rank of #12 in the Nursing: Oncology category, as well as a 2023 Q2 quartile ranking, it reflects a significant position within the oncology nursing community. The journal particularly emphasizes the dissemination of innovative practices, evidence-based care, and the psychosocial dimensions of cancer treatment, serving as an essential resource for researchers, practitioners, and students alike. While it maintains subscription access options, the journal is committed to fostering a community of knowledge in the United States and beyond. By focusing on the multifaceted challenges faced in oncology nursing, ONCOLOGY NURSING FORUM seeks to enhance patient outcomes and elevate nursing practice in oncology settings.

SUPPORTIVE CARE IN CANCER is a premier academic journal published by Springer, dedicated to advancing the understanding and management of supportive care for cancer patients. With a notable impact factor, the journal is recognized for its contribution to the fields of Oncology, Rehabilitation, and Nursing, achieving impressive rankings in Scopus, including Q1 for Oncology Nursing and Rehabilitation, and Q2 for general Oncology. Founded in 1993 and looking towards a promising future until 2024, it serves as a vital resource for researchers, professionals, and students engaged in these critical areas of healthcare. Although not an Open Access journal, its rigorous peer-reviewed articles provide valuable insights into innovative practices and evidence-based strategies that enhance patient quality of life during and after treatment. By bridging the gap between research and clinical practice, SUPPORTIVE CARE IN CANCER significantly influences patient outcomes and fosters interdisciplinary collaboration in patient support.

Frontiers in Oncology is a premier open access journal dedicated to advancing the field of oncology through innovative research and knowledge dissemination. Published by FRONTIERS MEDIA SA since 2011, this journal is based in Switzerland and holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, highlighting its significance in the academic community. With its commitment to open access, Frontiers in Oncology ensures that vital research is readily available to researchers, healthcare professionals, and students around the globe, enhancing collaboration and fostering breakthroughs in cancer research. The journal's robust Scopus rankings further illustrate its academic influence, with notable positions in the fields of Oncology and Cancer Research. By covering a wide range of topics within oncology, this journal serves as a vital resource, supporting the rapid evolution of cancer treatment, diagnostics, and patient care strategies.

Asia-Pacific Journal of Oncology Nursing, published by Elsevier Science Inc, serves as a vital resource for researchers, practitioners, and students involved in the fields of oncology and nursing within the Asia-Pacific region. Since its transition to Open Access in 2014, the journal has aimed to disseminate cutting-edge research and innovative practices that enhance the quality of nursing care in oncology. With its ISSN 2347-5625 and E-ISSN 2349-6673, this journal holds a Q3 rank in both Oncology and Nursing (Oncology Nursing) as of 2023, reflecting its commitment to addressing current challenges and advancements in the discipline. With a Scopus ranking of 252/404 in Medicine (Oncology) and 13/20 in Nursing (Oncology Nursing), it occupies a crucial position in the academic landscape, nurturing knowledge that directly impacts patient care in oncology settings. Located at STE 800, 230 Park Ave, New York, NY 10169, the journal encourages contributions that explore multifaceted aspects of oncology nursing from 2018 to 2024, making it an important platform for emerging voices and established experts alike.

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

The Australian Journal of Advanced Nursing, published by the Australian Nursing Federation, has established itself as a vital resource in the fields of nursing and advanced nursing practice since its inception in 1983. With an ISSN of 0813-0531 and an E-ISSN of 1447-4328, this peer-reviewed journal aims to disseminate high-quality research, innovative practices, and critical reviews that contribute to the advancement of nursing knowledge and education. With a commendable impact factor and currently positioned in the Q2 quartile in both Advanced and Specialized Nursing and miscellaneous Nursing categories as of 2023, the journal is ranked among the top publications in the field, reflecting its significance and influence in shaping nursing practices and policies in Australia and beyond. The journal provides open access options for a wider readership while specializing in progressive topics that address contemporary challenges in nursing, thus serving researchers, practitioners, and educators alike. It continues to be a cornerstone for advancing the professional development of nursing disciplines, supporting a community that thrives on evidence-based practice and interdisciplinary collaboration.

Cancer Nursing, a peer-reviewed journal published by Lippincott Williams & Wilkins, plays a pivotal role in the field of oncology nursing, providing a vital platform for the dissemination of research that enhances patient care and nursing practices related to cancer. With an impressive impact factor and categorized within the Q2 quartile for both oncology and nursing disciplines, this journal ranks among the top resources in its field, sitting at Rank #5 out of 20 in Nursing Oncology. Since its inception in 1978, the journal has continuously evolved to address critical issues in cancer treatment, patient education, and healthcare delivery, making it essential reading for researchers, practitioners, and students alike. Although it does not currently offer open access, the journal's commitment to advancing knowledge in oncology nursing is reflected in its rigorous selection process and the quality of its published research. As we look towards its upcoming issues in 2024, the journal remains a cornerstone for those dedicated to improving cancer care and the overall quality of life for patients and their families.

ONCOLOGY-NEW YORK is a prominent journal dedicated to the field of oncology, published by UBM MEDICA. Since its inception in 1987, the journal has served as a pivotal platform for disseminating groundbreaking research and advancements in cancer treatment, research, and education. With an ISSN of 0890-9091 and an E-ISSN of 2767-7389, it stands as an accessible resource for professionals, researchers, and students alike. The journal currently holds impressive rankings, categorized within Q3 in Oncology and Q4 in Cancer Research for 2023, reflecting its commitment to high-quality research output and contributions to the field. Despite its challenges in Scopus rankings, positioned at #283/404 in Medicine: Oncology and #188/230 in Biochemistry, Genetics, and Molecular Biology: Cancer Research, ONCOLOGY-NEW YORK continues to primarily focus on innovative cancer therapies and emerging clinical research. The journal's ongoing dedication to enhancing knowledge and understanding in oncology makes it a vital resource for all stakeholders invested in combating cancer.

The Journal of Pediatric Hematology-Oncology Nursing, published by SAGE Publications Inc, serves as a premier platform for advancing the field of pediatric nursing, particularly in the critical realms of hematology and oncology. With an ISSN of 2752-7530 and an E-ISSN of 2752-7549, this journal has quickly established its significance, achieving commendable rank status in various nursing specialties, including a Q1 placement in Advanced and Specialized Nursing as of 2023. It provides critical insights and evidence-based research across its converged years from 2022 to 2024, ensuring that professionals in the field remain at the forefront of best practices and innovations. The journal is especially relevant for nurses, medical professionals, and researchers aiming to improve patient outcomes in pediatric care. With open access options, it invites a broad readership to engage with its content, thus fostering collaboration and knowledge sharing in this vital area of healthcare.

Current Oncology is a prominent open-access journal dedicated to the field of oncology, published by MDPI in Switzerland. With an ISSN of 1198-0052 and E-ISSN 1718-7729, this esteemed journal has been providing valuable insights since its inception in 1998 and continues to publish cutting-edge research through 2024. Recognized for its contribution to the medical community, Current Oncology holds a 2023 Q2 category rank in Oncology and is positioned at the 41st percentile among its peers in Scopus rankings. As a hub for innovation and discussion in cancer research, it offers a plethora of articles that span various aspects of oncology, making it an essential resource for researchers, professionals, and students alike. Since becoming fully open-access in 2006, it provides expanded accessibility to groundbreaking studies and findings, fostering collaboration and knowledge exchange across the global research community. With its central location in Basel, Switzerland, Current Oncology plays a pivotal role in advancing oncology's frontiers.